- Price
- $87.90
- Day
- -2.02%
- Mkt Cap
- $33.17B
- 52W Range
- $54.11 – $92.59
- Volume
- 2.27M
- Beta
- 1.41
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Technical indicators have turned bullish for the three stocks.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. The live presentation is scheduled to begin at approximately 8:00 AM EDT and will be concurrently webcast. Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference. About DexCom, Inc. Dexcom em.
Read full article
American Capital Management Inc. bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 235,152 shares of the medical device company's stock, valued at approximately $15,837,000. American Capital Management Inc.
Read full article
ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.
Read full article
Great Lakes Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,472 shares of the medical device company's stock, valued at approximately $369,000. Other hedge funds also recently added to
Read full article
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
Aurora Investment Counsel bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 34,744 shares of the medical device company's stock, valued at approximately $2,340,000. DexCom comprises 1.2% of Aurora Investment Counsel's investment portfolio, making
Read full article
Dan Deming discusses why he sees sideways action in the stock market continuing through next week, noting anticipating for the Fed's Jackson Hole meeting. As for Thursday's Big 3, he sees an opportunity in Parker-Hannifin (PH) closing its stock gap, Dexcom (DXCM) maintaining recent upward momentum, and Union Pacific (UNP) becoming a leader in the railroad industry's comeback.
Read full article